New Market Report: PharmaPoint: Chronic Heart Failure - US Drug Forecast and ... USPRwire (press release) [USPRwire, Mon Aug 05 2013] GlobalData has released its new Country report, "PharmaPoint: Chronic Heart Failure - US Drug Forecast and Market Analysis to 2022". The chronic heart failure (CHF) market is a mature market that has been slowly overtaken ... |
